Search Results - "Garcovich, S."

Mass quarantine measures in the time of COVID‐19 pandemic: psychosocial implications for chronic skin conditions and a call for qualitative studies by Garcovich, S., Bersani, F.S., Chiricozzi, A., De Simone, C.

Get full text

The Effect of Autologous Activated Platelet Rich Plasma (AA-PRP) Injection on Pattern Hair Loss : Clinical and Histomorphometric Evaluation by Cervelli, V., Garcovich, S., Bielli, A., Cervelli, G., Curcio, B. C., Scioli, M. G., Orlandi, A., Gentile, P.

“…To investigate the safety and clinical efficacy of AA-PRP injections for pattern hair loss. AA-PRP, prepared from a small volume of blood, was injected on half…”
Get full text

Chronic nodular prurigo: clinical profile and burden. A European cross‐sectional study by Pereira, M.P., Hoffmann, V., Weisshaar, E., Wallengren, J., Halvorsen, J.A., Garcovich, S., Misery, L., Brenaut, E., Savk, E., Potekaev, N., Lvov, A., Bobko, S., Szepietowski, J.C., Reich, A., Bozek, A., Legat, F.J., Metz, M., Streit, M., Serra‐Baldrich, E., Gonçalo, M., Storck, M., Greiwe, I., Nau, T., Steinke, S., Dugas, M., Ständer, S., Zeidler, C., Dalgard, F., Elberling, J., Forner, C., Leslie, T., Riepe, C., Schneider, G., Ständer, H.

“…Background Chronic nodular prurigo (CNPG) is a condition characterized by chronic itch, a prolonged scratching behaviour and the presence of pruriginous…”
Get full text

Novel nicastrin mutation in hidradenitis suppurativa–Dowling–Degos disease clinical phenotype: more than just clinical overlap? by Garcovich, S., Tricarico, P.M., Nait‐Meddour, C., Giovanardi, G., Peris, K., Crovella, S., Boniotto, M.

Get full text

European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo by Pereira, M.P., Steinke, S., Zeidler, C., Forner, C., Riepe, C., Augustin, M., Bobko, S., Dalgard, F., Elberling, J., Garcovich, S., Gieler, U., Gonçalo, M., Halvorsen, J. A., Leslie, T.A., Metz, M., Reich, A., Şavk, E., Schneider, G., Serra‐Baldrich, E., Ständer, H.F., Streit, M., Wallengren, J., Weller, K., Wollenberg, A., Bruland, P., Soto‐Rey, I., Storck, M., Dugas, M., Weisshaar, E., Szepietowski, J.C., Legat, F.J., Ständer, S.

“…Background The term prurigo has been used for many decades in dermatology without clear definition, and currently used terminology of prurigo is inconsistent…”
Get full text

Cross‐European validation of the ItchyQoL in pruritic dermatoses by Zeidler, C., Steinke, S., Riepe, C., Bruland, P., Soto‐Rey, I., Storck, M., Garcovich, S., Blome, C., Bobko, S., Legat, F.J., Potekaev, N., Lvov, A., Misery, L., Weger, W., Reich, A., Şavk, E., Streit, M., Serra‐Baldrich, E., Szepietowski, J.C., Yosipovitch, G., Chen, S.C., Dugas, M., Ständer, S.

“…Background Chronic pruritus (CP) is a frequently occurring symptom in inflammatory dermatoses, causing a high burden and limitations to health‐related quality…”
Get full text

Self-management-competency as a new target in Hidradenitis suppurativa care by Mann, C, Staubach, P, Grabbe, S, Wegner, J, Hennig, K, Nikolakis, G, Szepietowski, J C, Matusiak, L, von Stebut, E, Kirschner, U, Podda, M, Garcovich, S, Schultheis, M

“…Hidradenitis suppurativa affects approximately 1% of the population. Highlighting the relevance of self-management-competency as a new therapeutic target. 258…”
Get full text

Comorbid acne inversa and Dowling–Degos disease due to a single NCSTN mutation: is there enough evidence? Reply from the authors by Garcovich, S., Tricarico, P.M., Meddour, C.N., Giovanardi, G., Peris, K., Crovella, S., Boniotto, M.

“…Linked Articles: Hermasch et al. Br J Dermatol 2021; 184:374. Garcovich et al. Br J Dermatol 2020; 183:758–759…”
Get full text

Post‐bariatric surgery hidradenitis suppurativa: a new patient subset associated with malabsorption and micronutritional deficiencies by Garcovich, S., De Simone, C., Giovanardi, G., Robustelli, E., Marzano, A. V., Peris, K.

“…Summary Background Bariatric surgery (BS) represents the most effective treatment for morbid obesity and its related complications, potentially ameliorating…”
Get full text

Pruritus Intensity Scales across Europe: a prospective validation study by Storck, M., Sandmann, S., Bruland, P., Pereira, M.P., Steinke, S., Riepe, C., Soto‐Rey, I., Garcovich, S., Augustin, M., Blome, C., Bobko, S., Legat, F.J., Potekaev, N., Lvov, A., Misery, L., Weger, W., Reich, A., Şavk, E., Streit, M., Serra‐Baldrich, E., Szepietowski, J.C., Dugas, M., Ständer, S., Zeidler, C.

“…Background Chronic pruritus (CP) is a subjective symptom, and it is necessary to assess its intensity with validated patient‐reported outcome tools in order to…”
Get full text

Chronic nodular prurigo: Association between comorbidities, itch and quality of life by Pereira, M. P., Gutsche, A., Weisshaar, E., Halvorsen, J. A., Wallengren, J., Legat, F. J., Garcovich, S., Savk, E., Reich, A., Bozek, A., Lvov, A., Bobko, S., Metz, M., Streit, M., Misery, L., Brenaut, E., Serra‐Baldrich, E., Goncalo, M., Szepietowski, J. C., Augustin, M., Zeidler, C., Ständer, S.

Get full text

Successful use of etanercept in a case of toxic epidermal necrolysis induced by rituximab by Didona, D., Paolino, G., Garcovich, S., Caposiena Caro, R.D., Didona, B.

Get full text

European EADV network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools by Ständer, S., Zeidler, C., Riepe, C., Steinke, S., Fritz, F., Bruland, P., Soto-Rey, I., Storck, M., Agner, T., Augustin, M., Blome, C., Dalgard, F., Evers, A.W.M., Garcovich, S., Gonçalo, M., Lambert, J., Legat, F.J., Leslie, T., Misery, L., Raap, U., Reich, A., Şavk, E., Streit, M., Serra-Baldrich, E., Szepietowski, J., Wallengren, J., Weisshaar, E., Dugas, M.

“…Background Chronic pruritus is a frequently occurring symptom of various dermatoses that causes a high burden and impaired quality of life. An effective anti…”
Get full text

Google search trends for itch in Europe: a retrospective longitudinal study by Pereira, M.P., Ziehfreund, S., Rueth, M., Ewering, T., Legat, F.J., Lambert, J., Elberling, J., Misery, L., Brenaut, E., Papadavid, E., Garcovich, S., Evers, A.W.M., Halvorsen, J.A., Szepietowski, J.C., Reich, A., Gonçalo, M., Lvov, A., Bobko, S., Serra‐Baldrich, E., Wallengren, J., Savk, E., Leslie, T., Ständer, S., Zink, A.

“…Background Itch is a common symptom in the general population. Affected individuals often do not seek medical consultation and rely on Internet searches to…”
Get full text

Frailty screening in dermato‐oncology practice: a modified Delphi study and a systematic review of the literature by Winden, M.E.C., Garcovich, S., Peris, K., Colloca, G., Jong, E.M.G.J., Hamaker, M.E., Kerkhof, P.C.M., Lubeek, S.F.K.

“…Background Appropriate management and prevention of both under‐ and overtreatment in older skin cancer patients can be challenging. It could be helpful to…”
Get full text

Frequency of circulating subpopulations of T‐regulatory cells in patients with hidradenitis suppurativa by Hessam, S., Gambichler, T., Höxtermann, S., Skrygan, M., Sand, M., Garcovich, S., Meyer, T., Stockfleth, E., Bechara, F.G.

“…Background Decreased number of T‐regulatory cells (Tregs) and/or their loss of function potentially lead to uncontrolled immune‐mediated inflammatory…”
Get full text

EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions by Ständer, S, Pereira, M P, Zeidler, C, Legat, F J, Misery, L, Lönndahl, L, Bewley, A P, Brenaut, E, Bobko, S, Elberling, J, Evers, A W M, Garcovich, S, Gieler, U, Gonçalo, M, Kupfer, J, Lambert, J, Lvov, A, Metz, M, Michenko, A, Papadavid, E, Reich, A, Savk, E, Schneider, G, Schut, C, Serra-Baldrich, E, Ständer, H F, Szepietowski, J C, Wallengren, J, Weisshaar, E, Augustin, M

“…Chronic pruritus (CP) is frequent in general medicine and the most common complaint in general dermatology. The prevalence of CP is expected to rise in the…”
Get full text

Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study by Garcovich, S., Ruggeri, A., D'Agostino, M., Ardito, F., De Simone, C., Delogu, G., Fadda, G.

“…Background  Psoriasis patients who are treated with tumour necrosis factor (TNF)‐alpha antagonists are at increased risk of reactivation of latent tuberculosis…”
Get full text

Position Statement: Linear prurigo is a subtype of chronic prurigo by Pereira, M.P., Zeidler, C., Nau, T., Bobko, S., Evers, A.W.M., Garcovich, S., Gonçalo, M., Halvorsen, J.A., Lambert, J., Legat, F.J., Leslie, T., Metz, M., Misery, L., Nordlind, K., Reich, A., Schneider, G., Ständer, H., Streit, M., Szepietowski, J.C., Wallengren, J., Weisshaar, E., Ständer, S., Augustin, M., Brenaut, E., Dalgard, F.J., Elberling, J., Gieler, U., Kupfer, J., Lvov, A., Mittal, A., Savk, E., Serra‐Baldrich, E., Steinke, S., Tschachler, E., Weller, K.

“…Background Chronic prurigo (CPG) is a distinct disease characterized by chronic pruritus, history and/or signs of prolonged scratching and multiple pruriginous…”
Get full text

Occurrence of hidradenitis suppurativa and phrynoderma after bariatric surgery by Garcovich, S., Di Stefani, A., Capizzi, R., Massi, G., Peris, K.

Get full text